The Food and Drug Administration (FDA) released a new policy aimed at restricting unnecessary antiobiotic use in livestock. In their final guidance document, released on Wednesday, December 11, the FDA requested that pharmaceutical companies create labels that would make it more difficult for livestock owners to use antibiotics as growth enhancers.
The two largest makers of such drugs have indicated they are willing to participate. As a part of the voluntary policy, the companies would also change the marketing status of these products, requiring them to would be sold with veterinarian oversight, rather over the counter.
Some public health advocates praised the decision, while others suggested it didn’t go far enough to restrict other, non-therapeutic uses of antibiotics.